Furthermore, the increased level of serum alpha-1 antitrypsin in SLE patients might provide beneficial information for the potential management of disease severity as well as both prevention and treatment, which is the translational medical development of SLE. The gene discussed is SERPINA1; the disease is systemic lupus erythematosus.